1997
DOI: 10.1086/513753
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Combination Therapy Regimens for Treatment of Human Immunodeficiency Virus–Infected Patients with Disseminated Bacteremia Due toMycobacterium avium

Abstract: We conducted a randomized, open-label trial in 42 French hospitals to compare the clinical and bacteriologic efficacy of combination therapy with clarithromycin/clofazimine (Clm/Clof) with that of combination therapy with clarithromycin/rifabutin/ethambutol (Clm/Rib/Eth) as treatment for Mycobacterium avium bacteremia. One hundred forty-four human immunodeficiency virus-seropositive patients older than 18 years of age who had CD4 lymphocyte counts of <100/mm3 and a blood culture positive for M. avium were enro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0
2

Year Published

1998
1998
2015
2015

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(17 citation statements)
references
References 17 publications
0
15
0
2
Order By: Relevance
“…During the present study, patients infected with M. kansasii were predominantly treated with rifampicin, ethambutol and isoniazid for 9 months, and only one relapse occurred. Patients with pulmonary MAC or M. xenopi disease are usually treated with multidrug regimens including rifampicin or rifabutin, ethambutol, isoniazid and clarithromycin [4,28,29]. In the current study, high mycobacterial clearance rates were observed when patients were treated with this combination plus another antibiotic, such as a fluoroquinolone.…”
Section: Discussionmentioning
confidence: 60%
“…During the present study, patients infected with M. kansasii were predominantly treated with rifampicin, ethambutol and isoniazid for 9 months, and only one relapse occurred. Patients with pulmonary MAC or M. xenopi disease are usually treated with multidrug regimens including rifampicin or rifabutin, ethambutol, isoniazid and clarithromycin [4,28,29]. In the current study, high mycobacterial clearance rates were observed when patients were treated with this combination plus another antibiotic, such as a fluoroquinolone.…”
Section: Discussionmentioning
confidence: 60%
“…The M. avium isolates included in the present study were obtained from the Institute Pasteur of Paris, Laboratoire de Référence des Mycobactéries, Paris, France (see Table S6 in the supplemental material). These isolates were all isolated from blood samples recovered from 93 AIDS patients over several months (14) and were typed by serotyping, by IS1245 RFLP analysis, in some cases by RFLP analysis with plasmids pVT2 and pLR7 as probes, and by pulsed-field gel electrophoresis (20).…”
Section: Methodsmentioning
confidence: 99%
“…More recently, macrolide-based combinations have improved survival compared with older regimens [16]. However, the long-term outcomes remained poor, and relapse still was common [17][18][19][20]. MAC infection remaining in tissue after the sterilization of blood is the probable source of relapses and may adversely influence longterm clinical responses.…”
mentioning
confidence: 99%